ADVFN Logo ADVFN
Donnée du Marché
Actualité
Outils
Donnée du Marché
Discover

Hot Features

Follow Feed

Rester connecter avec les traders et investisseurs dans notre communauté Follow Feed.

Flux des Options

Explorez des données complètes sur les options et utilisez les filtres avancés avec Options Flow.

Moniteur

Organisez et surveillez vos d'actions et actifs avec le Moniteur.
Se connecter Premium IconPremium Help Menu
CAC 40
8 088,24
0,89%
Dow Jones
38 239,66
0,40%
DAX
18 161,01
1,32%
Brent Oil
88,165
0,00%
Bitcoin
62 919,30
-1,29%
Registration Strip Icon for monitor Surveillez plusieurs cotations en temps réel des principales bourses, telles que Euronext Paris, NASDAQ, NYSE, AMEX, Bovespa et plus encore.
S'inscrire
  1. Accueil
  2. Investir
  3. Actions
  4. Etats-Unis
  5. NASDAQ
  6. Janux Therapeutics Inc (JANX)

  7. Janux Therapeutics Inc (JANX) Actualités

JANX Janux Therapeutics Inc

47,39
0,29 (0,62%)
27 Avr 2024 - Fermé
Retardé de 15 minutes
Nom Action Symbole Action Marché Type
Janux Therapeutics Inc JANX NASDAQ Action ordinaire
  Variation Action Variation Action% Cours Dernier Dernier échange
Upgrade Icon
0,29 0,62% 47,39 01:34:00
Ouverture Plus Bas Plus Haut Prix de clôture Clôture Veille
47,08 46,51 48,23 47,39 47,10
plus d'informations sur les cotations »

Actualités Recentes

Date Heure Source Titre
08/3/202422:47EDGAR2Form S-8 - Securities to be offered to employees in employee..
08/3/202422:23EDGAR2Form 10-K - Annual report [Section 13 and 15(d), not S-K..
08/3/202422:11EDGAR2Form 8-K - Current report
08/3/202422:01BWJanux Therapeutics Reports Fourth Quarter and Full Year 2023..
29/2/202423:30EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
29/2/202423:11EDGAR2Form 8-K - Current report
29/2/202407:22BWJanux Therapeutics Announces Pricing of $296.5 Million..
29/2/202403:55EDGAR2Form FWP - Filing under Securities Act Rules 163/433 of free..
28/2/202423:15EDGAR2Form 8-K - Current report
28/2/202403:50EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
27/2/202423:23EDGAR2Form 8-K - Current report
27/2/202423:00BWJanux Therapeutics Announces Proposed Public Offering of..
26/2/202422:05BWJanux Announces Encouraging Safety and Efficacy Data in..
20/2/202414:00BWJanux Therapeutics to Host Virtual Event Discussing Updated..
09/2/202422:31EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
01/2/202422:15EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
08/1/202415:00BWJanux Therapeutics Promotes Co-Founder Tommy DiRaimondo,..
03/1/202422:54EDGAR2Form 4 - Statement of changes in beneficial ownership of..
03/1/202422:53EDGAR2Form 4 - Statement of changes in beneficial ownership of..
03/1/202422:50EDGAR2Form 4 - Statement of changes in beneficial ownership of..
03/1/202422:49EDGAR2Form 4 - Statement of changes in beneficial ownership of..
03/1/202422:47EDGAR2Form 4 - Statement of changes in beneficial ownership of..
03/1/202422:45EDGAR2Form 3 - Initial statement of beneficial ownership of..
07/11/202322:19EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
07/11/202322:07EDGAR2Form 8-K - Current report
07/11/202322:01BWJanux Therapeutics Reports Third Quarter 2023 Financial..
08/9/202300:14EDGAR2Form 144 - Report of proposed sale of securities
14/8/202322:33EDGAR2Form 144 - Report of proposed sale of securities
08/8/202322:33EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
08/8/202322:17EDGAR2Form 8-K - Current report
08/8/202322:01BWJanux Therapeutics Reports Second Quarter 2023 Financial..
18/7/202323:24EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
18/7/202322:16EDGAR2Form 8-K - Current report
17/7/202314:45BWJanux Therapeutics Announces Pricing of $60 Million..
17/7/202314:16EDGAR2Form FWP - Filing under Securities Act Rules 163/433 of free..
17/7/202314:06EDGAR2Form 8-K - Current report
17/7/202314:00BWJanux Therapeutics Announces Positive Interim Clinical Data..
05/6/202322:35BWJanux Therapeutics Appoints Zachariah McIver, D.O., Ph.D.,..
09/5/202322:01BWJanux Therapeutics Reports First Quarter 2023 Financial..

Dernières Valeurs Consultées

NASDAQ
JANX
Janux Therapeutics
Delayed Upgrade Clock
ADVFN Logo

France
Société
Entreprise
Popular
Obtenir l'application

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales

© 2024 ADVFN PLC - Tous droits réservés